Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Current Leases (2022 - 2026)

Envoy Medical's Current Leases history spans 5 years, with the latest figure at $178000.0 for Q1 2026.

  • On a quarterly basis, Current Leases rose 22.76% to $178000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $178000.0, a 22.76% increase, with the full-year FY2025 number at $174000.0, up 21.68% from a year prior.
  • Current Leases hit $178000.0 in Q1 2026 for Envoy Medical, up from $174000.0 in the prior quarter.
  • Over the last five years, Current Leases for COCH hit a ceiling of $225000.0 in Q3 2024 and a floor of $125000.0 in Q4 2022.
  • Historically, Current Leases has averaged $166250.0 across 5 years, with a median of $163000.0 in 2023.
  • Biggest five-year swings in Current Leases: skyrocketed 51.01% in 2024 and later dropped 25.33% in 2025.
  • Tracing COCH's Current Leases over 5 years: stood at $125000.0 in 2022, then grew by 26.4% to $158000.0 in 2023, then fell by 9.49% to $143000.0 in 2024, then grew by 21.68% to $174000.0 in 2025, then rose by 2.3% to $178000.0 in 2026.
  • Business Quant data shows Current Leases for COCH at $178000.0 in Q1 2026, $174000.0 in Q4 2025, and $168000.0 in Q3 2025.